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.edu.cn (J.-t. TangAbstract Magnetic ﬂuid hyperthermia (MFH) promises to be a viable alternative in the treatment
of localized cancerous tumors. The treatment consists of introducing nanoparticles as energy
absorbent agents in tumor tissue under an oscillating magnetic ﬁeld, where nanoparticles dissipate
energy in the form of heat, causing a localized rise in the temperature and tumor cell death.
Traditional magnetic ﬂuid under study is artiﬁcial magnetic nanoparticles. This work seeks to
introduce the new natural biologic magnetic material bacterial magnetosomes (BMs) to be used in
MFH. Properties of magnetosomes and chemically synthesized magnetic nanoparticles (MNPs),
such as morphology, magnetic properties and their heating effects under magnetic ﬁeld were
compared. Cytotoxicity studies using human breast cancer cells MCF-7 indicated that cell viabilityesearch Society. Production
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R.-t. Liu et al.32could be signiﬁcantly decreased by the heat derived from BMs and MNPs under alternative
magnetic ﬁeld. Biocompatibility of BMs and MNPs was compared in terms of evaluating their
acute toxicity in mice and their decomposition abilities in vitro, and it showed that magnetosomes
exhibit a lower toxicity. These ﬁndings provide evidence for beneﬁcial activities of magnetosomes in
MFH and support the continued investigation of it to be applied in biomedicine.
& 2012. Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Currently, tumor extirpation, chemotherapy and radiotherapy
are the three main methods to treat cancer. Although count-
less lives have been saved by these approaches, they are not
always enough to eradicate the disease. Magnetic ﬂuid
hyperthermia (MFH) is one of the efforts that are being made
in treating tumors to allow the patient a better quality of life.
It involves injecting the ﬂuid containing magnetic nanoparti-
cles directly into tumors, and then the alternating magnetic
ﬁeld placed around the tumors will destroy them by heat
dissipated by the nanoparticles. MFH could prevent unneces-
sary heating in healthy tissues because only the magnetic
nanoparticles absorb the magnetic ﬁeld energy [1].
Magnetic nanoparticles in MFH are the materials that
absorb energy and turn it into heat, so they play a very
import part in the therapy. The increase in temperature should
depend on the magnetic properties of the material, the
frequency of oscillation, the strength of the magnetic ﬁeld
and so on. Until recently, most of the magnetic ﬂuid under
study is artiﬁcial magnetic nanoparticles, mainly in the form of
superparamagnetic iron oxide nanoparticles, such as amino
silane iron oxide nanoparticles and applications of the mag-
netic materials as heating mediator for hyperthermia with the
goal of tumor therapy have been studied in vitro, in vivo and
in human trials, with success [2,3]. Nowadays, concerns have
been raised regarding the toxicity induced by the presence of
the chemically synthesized nanoparticles though signiﬁcant
progress has been made in MFH, so efforts are being made in
order to optimize the features of nanoparticles.
Bacterial magnetosomes (BMs), which could be obtained by
biomineralization process in the magnetotactic bacteria, con-
sist of magnetic mineral crystals magnetite or greigite envel-
oped by biological membranes that contain phospholipids and
speciﬁc proteins [4]. BMs have attracted much attention in the
three decades since their unique feature making them could be
considered used as a new natural biologic magnetic material in
biomedicine. Studies have been performed to use BMs as
carrier, such as proteins, nucleic acids, antibodies or drug
[5–7], but have not been used as heating mediator in MFH. It
was shown that comparing with artiﬁcial magnetic nanopar-
ticles (MNPs), BMs exhibit better heating effects under the
same magnetic ﬁeld [8,9] and the lipid membrane on magneto-
some surface endowed them with better biocomparibility.
Although magnetic properties of BMs have been evaluated
[10] and it predicted that BMs could be considered as good
materials for the biomedical applications in hyperthermia
treatments [9], little has been done to compare the effects of
MNPs and BMs in hyperthermia. In this article, the heating
efﬁciency and antitumoral activity of BMs were evaluated,
comparing with superparamagnetic chemically synthesizedmagnetic nanoparticles (MNPs), which are currently being
tested for MFH [3], and hyperthermia was performed using
hot water or the two kinds of particles. Biocompatibility of
BMs and MNPs was also compared in the form of their acute
toxicity in mice. The results showed that BMs possess a
promising applicable prospect in the magnetic induction
hyperthermia ﬁeld for their special conﬁguration.2. Material and methods
2.1. Materials
BMs were isolated from M. gryphiswaldense MSR-1 based on
the previously described method [11]. Spherical Fe3O4 MNPs
with amino silane as the capping agent were synthesized by
co-precipitation in our lab [12]. BMs and MNPs were
sterilized by Co60 (15 kGy) before injection.
Male and Female Bal/c mice (18–22 g) purchased from
Laboratory Animal Center of Tsinghua University were used
to estimate the acute toxicity of the nanoparticles. These mice
were housed with free access to standard food and water at a
room temperature of 2172 1C, relative humidity of 45715%
and a 12 h-light/dark cycle. All animal experiments were
conducted in accordance with the National Institutes of
Health Guide for the care and use of Laboratory animals
and a protocol approved by the guidelines of the Chinese
Society of Laboratory Animal Sciences. Every effort was made
to minimize the suffering of the animals and the number of
animals used.
2.2. Examination of physical properties of particles
The morphology of BMs and MNPs were viewed by electron
microscope (TEM) H-800 (Brookhaven Instruments Corp.,
USA), and crystal-size distributions were quantiﬁed by mea-
suring the average particle size. Vibrating sample magnet-
ometer (VSM) was used to measure the magnetic properties of
BMs and MNPs, and the measurements were carried out in
the ﬁeld region of 71 T at room temperature.
2.3. Heating effect of particles
Magnetic particles could absorb energy from the alternating
magnetic ﬁeld and converting it into heat. So, inductive heating
property of the BMs and MNPs of a serious concentrations
(diluted in PBS) were performed by exposing the particles
under the alternative magnetic ﬁeld (AMF) of frequency of
300 kHz and ﬁeld amplitude of 110 Gs generated by inductive
heating device (Shuangping Instrument Technology, Co., Ltd,
Shenzhen, China). Thermal-couple temperature probe (Model
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for the temperature measurement. The probe ﬁbers were
connected to a four-channel millivoltmeter (Model XSOL-4,
Beijing Kunlun Tianchen Instrument Technology, Co., Ltd,
Beijing, China) and the data of sample temperature were
collected every 12 s by PC with home-written software.
2.4. Heating treatment by water bath
Human breast cancer cells MCF-7 and mouse ﬁbroblasts
(L-929) cells were cultured in 1640 medium supplemented
with 10% fetal calf serum in 5% CO2 humidiﬁed atmosphere
at 37 1C. Cells were fed three times a week with fresh medium
and passaged when 80% conﬂuent. Cells were seeded at a
concentration of 8000 cells/well in 96-well assay plates and
grown for 1 day at 37 1C and 5% CO2 before treatment. The
next day, the plates were placed in hot water bath at a series of
temperatures (45 1C, 47 1C, 50 1C) for a period of 30 min.
Cell viability was measured using 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl- tetrazolium bromide (MTT) assay. In brief,
culture media was added with MTT (ﬁnal concentration:
0.5 mg/ml) at 37 1C in a 5% CO2 incubator for 4 h, then the
media was replaced with 150 ml dimethyl sulphoxide. After
gentle stirring, the optical density (OD) of the samples was
then read with a microplate reader for ELISA (UNICO, UV-
2000; 540 nm). The inhibition ratio of every treated group was
calculated using the formula: Inhibition ratio¼(ODcontrol
ODtreated)/ODcontrol 100%.
2.5. Magnetic ﬂuid hyperthermia
MCF-7 cells were cultured as described above. Cells were
detached from the culturing ﬂask by trypsinization, resus-
pended in culture media and counted. A concentration of
1 105 cells/well were seeded in 6.5 mm Transwell ﬁlter inserts
(Millipore), which were placed in 24-well assay plates. The
next day, 10 mg/ml BMs or 15 mg/ml MNPs (the concentra-
tions were chosen according to the preliminary experiments)
were added into the 24-well plates, and the cells were subjected
to AMF of 300 kHz, 110 Gs generated by inductive heating
device (Shuangping Instrument Technology, Co., Ltd, Shenzhen,
China), and cells under the same condition but without applying
with AMF were served as control. A circulator bath was used to
maintain the ambient temperature surrounding the plates
around 37 1C. Thermal-couple temperature probe was applied
for the temperature measurement. Samples took an average of
2 min to reach the desired temperature, after which exposure
time started. The next day, the cells’ viabilities were analyzed
using MTT assay.
2.6. Decomposition of nanoparticles analysis in vitro
To simulate intracellular lysosomal conditions, BMs and
MNPs at a concentration of 0.1 mg/ml were suspended in a
solution of 0.1 mg/ml crude protease from bovine pancreas
(Sigma) in 1 ml of PBS solution at 37 1C under constant
stirring. The solution of pH was adjusted by the titration of
1.0 M HCl and 1.0 M NaOH to achieve pH values of 5.6 (the
pH condition in lysosomes in vivo). Following incubation for
1, 3, 7, 14 and 28 day, the nanoparticle suspensions were
viewed under TEM.2.7. Acute toxicity analysis in vivo
Nanoparticles were suspended in 0.9% sterile NaCl solution,
and they were injected into the caudal vein of the mice (n¼10/
group, 5/sex; MNPs dosage: 135, 180, 240 mg/kg; BMs
dosage: 270, 360, 480 mg/kg), and the group of control was
treated with the same volume of saline (10 ml/kg). The doses
were based on the preliminary tests. After the single treatment
with nanoparticles, mice were observed frequently during the
ﬁrst 4 h; thereafter observed every 8 h and weighed every 24 h.
If the animal died, the time of death was recorded, and the
nature of adverse effects was noted. Dead animals were
autopsied and examined macroscopically for any pathological
changes. These mice were observed for 14 days before
sacriﬁced, and blood samples were taken for routine examina-
tion, liver and kidney function tests. Hearts, livers, spleens,
lungs, kidneys and brains were removed, weighed and sec-
tioned for hematoxylin-eosin (HE) staining to observe under-
lying pathological changes.
2.8. Data analysis
Statistical analysis was conducted using SPSS (SPSS Inc.,
Chicago, IL). Results were compared among groups by one-
way ANOVA followed by Dunnett’s test. Po0.05 was
assumed to indicate statistical signiﬁcance.3. Results
3.1. Analysis of particle morphology
TEM images of BMs and MNPs were presented in Fig. 1. We
can see from Fig. 1a that cubo-octahedral BMs isolated from
MSR-1 were dispersed very well and were often arranged in
chains or sticking together. As it was reported before [4], lipid
magnetosome membranes (MMs) were found surrounding
every BM. Compared with BMs, MNPs were spherical and
seemed more likely to aggregate.
We measured the dimensions of BMs and MNPs and found
nearly 50% size of BMs distributed from 35 nm to 50 nm
(mean size 40 nm), while the maximum of the size distribution
range of MNPs was 6 nm to 15 nm, and had a mean size of
10 nm.
3.2. Analysis of magnetic properties
Fig. 2 shows the magnetization (M) versus ﬁeld (H) curve at
300 K for the two samples. From the curves, we can see that
BMs has a coercivity of 52.366 Oe and remnance of
34.140 emu/g, existing ferromagnetic behavior. Compared
with BMs, the coercivity of MNPs was 4.0810 Oe, and the
remnance was 65.227 emu/g, existing superparamagnetic beha-
vior. The results showed that both BMs and MNPs had high
magnetic response due to their perfect crystallinity.
3.3. Heating effect of particles
The heating proﬁles of BMs and MNPs in different concen-
trations under AMF of 300 kHz were shown in Fig. 3. As
shown in the ﬁgures, higher particle concentrations resulted in
Fig. 1 TEM images of BMs (a, b, c) and MNPs (d). MMs stands for magnetosome membranes.
Fig. 2 Magnetization curve of BMs and MNPs obtained by VSM. (b) is an enlargement of (a). From the curves we can see that BMs
show ferromagnetic behavior while MNPs show superparamagnetic behavior.
R.-t. Liu et al.34greater temperature increasing. And compare the two kinds of
nanoparticles, the heating effects of BMs seemed better than
that of MNPs. Take 47 1C for example, BMs needed 1.3, 0.7
and 0.4 min to reach the temperature, in the concentration of
10, 15 and 20 mg/ml, respectively, while the time for MNPs in
the same concentration was 1.9, 1.5 and 0.7 min.3.4. Heating treatment by water bath in breast cancer cells
Hot water hyperthermia were performed at three tempera-
tures, 45 1C, 47 1C and 50 1C, with an exposure period of
30 min. Inhibitory rates of hot water were analyzed 24 h after
application. As we can see in Fig. 4a, when it was 45 1C, the
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cells. The thermal dose of 47 1C exhibited an inhibitory rate of
62.2% and 53.2% to MCF-7 and L929 cells, respectively.
When the temperature reached 50 1C, 69.9% of the L929 cells
and 82.3% of the MCF-7 cells died, indicating tumor cells are
more sensitive to heat treatment.3.5. Magnetic ﬂuid hyperthermia
MFH was performed by using BMs or MNPs suspensions.
The temperature of the media was continuously monitored
during magnetic ﬁeld application with a ﬂame couple. With
the purpose of comparing hot water hyperthermia with that
resulting from energy dissipation from magnetic nanoparticles,
the intermediate thermal dose of 47 1C was applied by
controlling the intensity of the magnetic ﬁeld. It was found
that the magnetic ﬁeld intensity of 138 Gs was needed to
generate the thermal dose of 47 1C.
Both of the cell inhibitory rates were around 80% when
using BMs and MNPs under AMF (Fig. 4b). Compare with
that of 60% in hot water hyperthermia under the same
thermal dose, magnetic ﬂuid hyperthermia induced a more
signiﬁcant reduction in cell viability. It could be seen that the
viability of cells remained high in the absence of AMF,Fig. 3 Variation of temperature of suspension containing BMs
or MNPs of different concentrations. The suspension was exposed
to an AMF frequency of 300 kHz and ﬁeld amplitude of 110 Gs.
Fig. 4 Viability analysis of cells exposed to various modes of hyperth
hyperthermia in thermal doses of 45 1C, 47 1C and 50 1C. (b) MCF-7 ce
of 47 1C. The inhibition ratio was detected by MTT assay. Data are e
each condition was tested in triplicate for each assay. Po0.05 contrindicating the viability reduction was due to the AMF. In
addition, compared with MNPs, lower concentration of BMs
was needed to generate the thermal dose, indicating that BMs
have better heating effect than MNPs.
3.6. Decomposition of nanoparticles analysis in vitro
Crude protease from bovine pancreas in 1 ml of PBS solution
at pH of 5.6 was used to simulate intracellular lysosomal
conditions, and BMs and MNPs of 0.1 mg/ml were incubated
in the solution for 1, 3, 7, 14, 28 and 42 days with constant
stirring at 37 1C. We can see from Fig. 5 that BMs seemed not
intact and were surrounded by some cloud form in 28 day
time, indicating BMs were decomposed. And when imaged in
42 day time, we could hardly found any BMs, just some of
their remnants. While for MNPs, the morphology of them
seemed have not changed much compared with new ones.
3.7. Acute toxicity analysis in vivo
Suspensions of nanoparticles were injected into the caudal vein
of the mice, and the mortalities of mice injected with 135, 180
and 240 mg/kg MNPs were 30%, 50% and 67.70%, respec-
tively. Most of the dead mice died during the 4 h after
injection, but the surviving mice showed normal behavior
and increased weight over the course of the experiment. In the
groups of BMs-treated, all mice survived except one treated
with the high dose of BMs (480 mg/kg). But some of the
surviving mice injected with BMs showed slight listlessness
and decreasing weight during the ﬁrst four days, after which
they recovered (Supplementary Fig. A.1).
The surviving mice were sacriﬁced in the 14th day after
nanoparticles were injected. The major organs were removed
and weighed. TEM examination of ultrathin sections from
livers showed the presence of BMs and MNPs in liver cells.
Endocytotic vesicles containing BMs were usually merged with
lysosomes, but vesicles containing MNPs did not seem to
merge with lysosomes (Fig. 6). It indicated that BMs and
MNPs may undergo different decomposition in the liver. In
addition, prussian blue staining was performed in the sections
of major organs of mice to study the nanoparticle distribution.
In both MNPs and BMs mice, sporadic blue particles were
seen in the livers and spleens (Supplementary Fig. A.2). The
results of organ coefﬁcients in the mice, liver and kidneyermia. (a) MCF-7 cells and L929 cells were exposed to hot water
lls were exposed to MFH using BMs or MNPs in the thermal dose
xpressed as mean7S.E.M. Assays were repeated three times and
ol, DPo0.05 between the two kinds of cells.
Fig. 5 Representative TEM images of BMS and MNPs decomposed by crude protease in vitro. It seems that BMs could hardly be found
in 42 days time, while the morphology of MNPs have not changed too much.
R.-t. Liu et al.36function examinations and routine blood tests are shown in
supplementary data.4. Discussion
Ideal methods of cancer treatment would successfully achieve
tumor ablation at all stages of the cancer disease in a
noninvasive manner and with a minimum of side effects. In
this view, thermotherapy consisting of heating tumors to death
appears to offer a suitable method. Despite many advantages,
development of thermotherapy is limited mainly because of the
lack of tissue speciﬁcity. Metallic nanoparticles offered a break-
through in the improvement of thermotherapy speciﬁcity to
solve the difﬁculties related to targeting the irradiation area,
giving a new chance of rapid clinical development of thermo-
therapy [13]. Actually, the iron oxide nanoparticle has been used
for more than 10 years in MRI [14], and it seems a safe material
for thermotherapy in clinical trails [3]. The unique physicochem-
ical properties of nanoparticles are of importance for the
biomedical uses. Generally, ideal heating material used in
MFH should have the following characteristics: ﬁrst, satisfac-
tory heating effect under AMF; second, favorable physicochem-
ical properties, including the magnetic characterization, crystal
size, crystallinity, stability, dispersity and so on. Last but not theleast, the material must have high biocompatibility, which
means that it should be safe enough for medical use. BMs have
been receiving attention since 1975 [15], and they were suggested
as potential diagnostic and therapeutic tools recently [8]. As an
exploratory study, the present work attempts to introduce the
natural nanoparticle BMs to be used in the promising thermo-
therapy of tumors.
Increased heating ability of nanoparticles is one of the
most important challenges in order to minimize the dosage of
magnetic ﬂuid needed to reach therapeutic temperatures in
MFH. By exposing MNPs and BMs under the AMF of
300 kHz, we found that BMs exhibit a higher heating speed
and temperature, which is consistent with the previous
studies [9], so lower concentration of BMs was needed to
generate the quantity of heat in MFH, as indicated in the
present study. On the reasons for the increasing heating
ability, we hypothesize that the different particle size could
be one of the most important causes for it, as it has been
predicted that there is an optimum particle size, which would
yield the highest heating rate for a given set of measurement
conditions [16]. So, it could be presumed that chemically
synthesized nanoparitcles could potentially have the similar
heating ability as BMs if they were enlarged to 40 nm.
However, it has been proved that it has not yet reached the
heating efﬁciency of BMs, even not as good as MNPs of
Fig. 6 Representative TEM images of livers in mice treated with BMs or MNPs. (a) Liver of mice injected with BMs, the arrows indicate
BMs. (b) A partial enlarged image of BMs in the liver. (c) Liver of mice injected with MNPs, the arrows indicate MNPs. (d) A partial
enlarged image of MNPs in the liver.
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synthesize monodomain, well-crystallized ferromagnetic
nanoparticles with good stability. Secondly, the different
magnetic properties of BMs and MNPs could be another
reason. Compared with MNPs modiﬁed with amino silane,
we can see that both of the coercivity and area of the
hysteresis loops of BMs increased, so the increased hysteresis
losses may give rise to the enhanced heating capacity.
Thirdly, it was reported that BMs have better crystallinity
than synthetic MNPs [17], therefore, anisotropy of the
nanoparticles (shape or magnetocrystalline) could be the
other factor that inﬂuences the heating effect [10]. Of course,
the exact mechanisms still need further exploration.
The unique features of nanoparticles will decide their beha-
viors in MFH. In the present work, we compared the difference
in physicochemical properties of MNPs modiﬁed with amino
silane and BMs. From the characterization analysis we can see
that the magnetic properties of BMs and MNPs are different.
Synthetic MNPs show superparamagnetic characteristics with
zero hysteresis cycle, while BMs are ferromagnetic, existing
hysteresis losses. It has been shown that the transition from
superparamagnetic to ferromagnetic behavior occurs at a critical
size of 25 nm for ultra ﬁne magnetically ordered particles [18].
Thus, the different magnetic properties of BMs and MNPs may
be largely due to their different size. We can also see that the
saturation magnetization of MNPs (65.227 emu/g) is larger thanthat of BMs (34.140 emu/g), and this may be due to the presence
of the nonmagnetic MMs of 3–5 nm thickness outside the BMs.
It has been demonstrated that the MMs is not only critical for
the control of crystal size and morphology, but also prevents the
aggregation of extracted magnetosomes and thus stabilizes
magnetosome suspensions [4]. So, the presence of biocompatible
phospholipid membranes around BMs is one of its outstanding
peculiarities compared with the artiﬁcial MNPs, with some
functional groups on its surface as determined by FTIR.
Traditional therapeutic temperature range in hyperthermia
against tumor is 42 1C–45 1C [1]. This approach can destroy
tumors with minimal damage to healthy tissues. We found in
the previous study that a higher heating dose above 45 1C
could kill more cancerous cells, requiring less time of therapy
and is able to stimulate the autologous immunity of the
patients [19], thus the therapy effects are more satisfactory.
Accordingly, the heating dosages we used in the present paper
were all between 45 1C and 50 1C. In water-bath hyperthermia,
we could see that compared with tumor cells MCF-7, normal
cells L929 are less sensitive to heat, showing a relatively higher
survival rate. In MFH in vivo, the heating dosage of 47 1C was
chosen because the inhibitory rate of heat against tumor cells
was high, and it is a relatively safe dosage. The inhibitory rate
of 80% was relatively lower than that of it in water-bath
hyperthermia at 47 1C (62.2%), indicating the MFH protocol
actually resulted in a slightly higher thermal dose compared
R.-t. Liu et al.38with hot water protocol, which is consistent with the previous
studies [20]. Moreover, we found that compared with MNPs
modiﬁed with amino silane, less BMs are needed to reach the
therapeutic temperature, indicating the heating effect of BMs
is better, which is favorable for the application in the future,
because dosages of magnetic ﬂuids could be minimized.
Biocompatibility of amino silane-modiﬁed MNPs and BMs
was evaluated in the form of acute toxicity in mice. Different
dosages of the two kinds of particles were utilized according to
the preliminary test. We can see from the results that 50% of
the mice died when administrated with 180 mg/kg MNPs,
and only one mouse died in the highest dosing group of BMs
(480 mg/kg), indicating the toxicity of BMs is weaker than that
of MNPs modiﬁed with amino silane, although mice exposed to
BMs were slightly listless during the ﬁrst 4 days. LD50 is an
important value for evaluation of biocompatibility, but we have
not calculated the accurate LD50 because it would require more
mice to die, and the aim of the present paper is only to compare
the acute toxicity between MNPs and BMs. However, it can be
supposed that the LD50 of MNPs is around 180 mg/kg, and the
LD50 of MNPs will exceed 480 mg/kg. This prediction of LD50
of BMs is much higher than the previous study [21], we analyze
that it may attribute to the following reasons: ﬁrst, compared
with mice, rats may be more susceptible to the particles, as
sensitivity could be different between species. Secondly, differ-
ent approaches of evaluating acute toxicity were utilized. In the
previous study, ‘‘up-and-down’’ procedure was used, and only
one rat was used per group for evaluating. In the present study,
ten mice were used per group as mortality was required to
compare the toxicity of MNPs and BMs, so the result may be
more accurate. Anyhow, we could see that BMs may serve as a
new potential material in MFH.
From the pathological sections, TEM images and organ
coefﬁcient analysis after mice were sacriﬁced, it could be seen
that spleen and liver are the two major organs where
nanoparticles distribute, and they are supposed to be digested
by lysosomes. So the reticuloendothelial system, which is
mainly comprised with macrophages of livers and spleens, is
supposed to remove the particles from the bloodstream after
intravenous administration, as detected in other studies [22].
In addition, decomposition of the two kinds of nanoparticles
was analyzed in vitro, simulating the intracellular lysosomal
conditions. We could see that BMs are more easily decom-
posed, with only remnants in 42 days time. That is a good
phenomenon because it indicates that the biosynthetic BMs
may be more easily eliminated by the organisms after they
produce their effects, thereby exhibiting a lower toxicity.
As a pioneer study, the present work introduced the
biomaterial BMs as energy-absorption agents to be used in
MFH. It could be heated under AMF and induce cells to
necrosis, the compatibility of BMs with tissues is high. In the
future, in vivo studies aiming to evaluate the tumor ablating
effects using BMs should be developed, and the toxicological
proﬁle of the nanoparticles and their in vivo fate after long-
term survival in the body should be documented. Of course,
since only amino silane-modiﬁed MNP was used in the study,
the difference between BMs and MNPs modiﬁed with other
methods deserves more research. Hopefully, this work helps
introduce biologists and medical scientists to the tremendous
potential of this young ﬁeld and, in the process, inspires
some to join the small but growing list of magnetosome
researchers.5. Conclusions
To sum up, by comparing with MNPs modiﬁed with amino
silane, which is commonly used in biomedicine, BMs exhibit a
better heating effect under AMF. Using MNPs and BMs of
the same concentration, they could both enhance reduction in
cell viability by hyperthermia, but current of lower intensity is
needed by BMs to produce a similar inhibitory effect in the
tumor cell. The acute toxicity evaluation in mice shows that
the lethal dose BMs is much higher than MNPs, indicating the
relatively high biocompatibility of BMs. Liver and spleen are
the major organs where the two kinds of particles distribute.
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